VRT 0.99% $6.15 virtus health limited

The VRT result was, IMO, quite mixed. The BAD 1. Loss of market...

  1. 4,960 Posts.
    lightbulb Created with Sketch. 33
    The VRT result was, IMO, quite mixed.

    The BAD
    1. Loss of market share of 1.8% and from the presentation, appears to have lost share for 4 years
    2. Revenue down and costs up gave a poor profit result
    3. Had to "borrow" cash to pay dividend. i.e. - cash flow was not enough to pay CAPEX and dividends.
    4. page 22 of the presentation reported net capex which is quite misleading, it paints a picture of positve cash flow which, IMO, is wrong.

    The GOOD
    1. Dignostics had a great year with a 37% improvement in EBITDA
    2. Diversification of revenue is providing some buffer to the business
    3. Have taken steps to arrest market share decline - particularly in Vic.
    4. Plan for cost savings of $5m in FY18 is excellent news.

    The Ugly
    1. The balance sheet has 84% of the assets as intangibles.

    HT1
 
watchlist Created with Sketch. Add VRT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.